Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
M Stoll, … , R Metzger, T Unger
M Stoll, … , R Metzger, T Unger
Published February 1, 1995
Citation Information: J Clin Invest. 1995;95(2):651-657. https://doi.org/10.1172/JCI117710.
View: Text | PDF
Research Article Article has an altmetric score of 3

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

  • Text
  • PDF
Abstract

Angiotensin II (ANG II) is known to be a potent growth promoting factor for vascular smooth muscle cells and fibroblasts but little is known about its influence on growth in endothelial cells. We studied the effects of ANG II on endothelial growth and the role of the angiotensin receptor subtypes involved. Proliferation of rat coronary endothelial cells (CEC) and rat vascular smooth muscle cells (VSMC) was determined by [3H]thymidine incorporation, the MTT-test and by directly counting cells in a coulter counter. Angiotensin AT1- and AT2-receptors were demonstrated by binding studies and by the presence of their respective mRNA through reverse transcription polymerase chain reaction (RT-PCR). In contrast to VSMC, which in culture only express the AT1-receptor, CEC express both, AT1- and AT2-receptors simultaneously up to the third passage. Whereas ANG II stimulated growth of quiescent VSMC, an effect abolished by pretreatment with the AT1-receptor antagonist, losartan, ANG II did not induce proliferation in quiescent CEC. However, after pretreatment of quiescent endothelial cells (< passage 4) with the AT2-receptor antagonist, PD 123177, ANG II induced proliferation. This effect was reversed by additional pretreatment with losartan. ANG II significantly inhibited the proliferation of bFGF-stimulated CEC in a dose-dependent manner by maximally 50%. This effect was prevented by PD 123177 while losartan was ineffective. The AT2-receptor agonist, CGP 42112, mimicked the antiproliferative actions of ANG II, confirming the specificity of the effect. Our results show that the growth modulating actions of ANG II depend on the type of angiotensin receptor present on a given cell. In coronary endothelial cells, the antiproliferative actions of the AT2-receptor offset the growth promoting effects mediated by the AT1-receptor.

Authors

M Stoll, U M Steckelings, M Paul, S P Bottari, R Metzger, T Unger

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 Total
Citations: 1 5 2 4 4 2 5 3 5 3 12 4 9 15 16 25 16 18 16 16 29 28 30 39 54 50 69 61 54 45 11 651
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2012 (15)

Title and authors Publication Year
Local Fetal Lung Renin-Angiotensin System as a Target to Treat Congenital Diaphragmatic Hernia
C Nogueira-Silva, E Carvalho-Dias, P Piairo, S Nunes, MJ Baptista, RS Moura, J Correia-Pinto
Molecular Medicine 2012
The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro
D Ptasinska-Wnuk, SA Mucha, H Lawnicka, J Fryczak, J Kunert-Radek, M Pawlikowski, H Stepien
Endocrine 2012
Impact of the AT2 Receptor Agonist C21 on Blood Pressure and Beyond
S Foulquier, UM Steckelings, T Unger
Current Hypertension Reports 2012
Angiotensin II modulates VEGF-driven angiogenesis by opposing effects of type 1 and type 2 receptor stimulation in the microvascular endothelium
J Carbajo-Lozoya, S Lutz, Y Feng, J Kroll, HP Hammes, T Wieland
Cellular Signalling 2012
Angiotensin II type 2 receptor agonists: where should they be applied?
K Verdonk, AH Danser, JH van Esch
Expert Opinion on Investigational Drugs 2012
Muscle
ML Martin, SL Belmonte, R Ram, FA Kamal, BC Blaxall
Muscle 2012
Update on the Angiotensin AT2 Receptor
CA McCarthy, RE Widdop, KM Denton, ES Jones
Current Hypertension Reports 2012
AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression
P Namsolleck, F Boato, K Schwengel, L Paulis, K Matho, N Geurts, C Thöne-Reineke, K Lucht, K Seidel, A Hallberg, B Dahlöf, T Unger, S Hendrix, UM Steckelings
Neurobiology of Disease 2012
Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth
A Kawabata, A Baoum, N Ohta, S Jacquez, GM Seo, C Berkland, M Tamura
Cancer research 2012
Statins and selective inhibition of Rho kinase protect small conductance calcium-activated potassium channel function (K(Ca)2.3) in cerebral arteries
AJ McNeish, F Jimenez-Altayo, GS Cottrell, CJ Garland
PloS one 2012
A Non-peptide Angiotensin II Type 2 Receptor Agonist Does Not Attenuate Post-Myocardial Infarction Left Ventricular Remodeling in Mice
AB Jehle, Y Xu, JM DiMaria, BA French, FH Epstein, SS Berr, RJ Roy, BA Kemp, RM Carey, CM Kramer
Journal of Cardiovascular Pharmacology 2012
A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex
B Peters, D Podlich, M Ritter, A Müller, H Wanka, C Maser-Gluth, C Seitz, L Boni, E Maier, N Gretz, J Peters, SC Hoffmann
American journal of physiology. Endocrinology and metabolism 2012
Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation
J Kim, HJ Jang, LA Martinez-Lemus, JR Sowers
American journal of physiology. Endocrinology and metabolism 2012
Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKβ1/2 and Cdk4
YC Kim, RM Day
American journal of physiology. Lung cellular and molecular physiology 2012
The effect of losartan on angiotensin II-induced cell proliferation in a rat aorta smooth muscle cell line
N Tambelline, K Oliveira, LR Olchanheski, R Sordi, MF Otuki, GM Favero, D Fernandes
Brazilian Archives of Biology and Technology 2012

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
94 readers on Mendeley
See more details